Cotadutide
Safety and Tolerability Study of Cotadutide in Japanese Obese Subjects With Type 2 Diabetes Melitus
AstraZeneca · Phase 1 · Completed · Enrollment 16
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Placebo | n/r | n/r | n/r | n/r |
| Cotadutide | n/r | n/r | n/r | n/r |
Not shown
- Placebo: endpoint not reported
- Cotadutide: endpoint not reported